Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dhainaut

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Discovery|November 19, 2024
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular CarcinomaKatherine E Lindblad, Romain Donne, Ian Liebling, et al.
Stem Cells (Dayton, Ohio)|March 19, 2016
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell ImplantsChloé J Hoornaert, Evi Luyckx, Kristien Reekmans, et al.
Cell|March 15, 2022
Spatial CRISPR genomics identifies regulators of the tumor microenvironmentMaxime Dhainaut, Samuel A Rose, Guray Akturk, et al.
Cancer Discovery|June 13, 2019
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular CarcinomaMarina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, et al.
Nature|June 17, 2021
Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cellsMaría Casanova-Acebes, Erica Dalla, Andrew M Leader, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Discovery|November 19, 2024
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular CarcinomaKatherine E Lindblad, Romain Donne, Ian Liebling, et al.
Stem Cells (Dayton, Ohio)|March 19, 2016
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell ImplantsChloé J Hoornaert, Evi Luyckx, Kristien Reekmans, et al.
Cell|March 15, 2022
Spatial CRISPR genomics identifies regulators of the tumor microenvironmentMaxime Dhainaut, Samuel A Rose, Guray Akturk, et al.
Cancer Discovery|June 13, 2019
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular CarcinomaMarina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, et al.
Nature|June 17, 2021
Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cellsMaría Casanova-Acebes, Erica Dalla, Andrew M Leader, et al.
Pageof 2